Clari Vest Asset Management LLC Biocryst Pharmaceuticals Inc Transaction History

Clari Vest Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$9.5 - $17.24 $570,000 - $1.03 Million	-60,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$7.37 - $13.61 $25,058 - $46,274	3,400 Added 6.01%	60,000 $611,000
Q4 2020 Feb 09, 2021	SELL	$3.37 - $8.61 $64,030 - $163,590	-19,000 Reduced 25.13%	56,600 $422,000
Q3 2020 Nov 09, 2020	SELL	$3.43 - $5.53 $15,778 - $25,438	-4,600 Reduced 5.74%	75,600 $260,000
Q2 2020 Aug 12, 2020	SELL	$1.9 - $5.61 $8,550 - $25,245	-4,500 Reduced 5.31%	80,200 $382,000
Q1 2020 May 04, 2020	BUY	$1.6 - $4.11 $135,520 - $348,117	84,700 New	84,700 $169,000
Q3 2019 Nov 12, 2019	SELL	$2.5 - $3.73 $377,495 - $563,222	-150,998 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$2.91 - $9.15 $244,149 - $767,685	-83,900 Reduced 35.72%	150,998 $572,000
Q1 2019 May 13, 2019	BUY	$7.38 - $9.72 $27,306 - $35,964	3,700 Added 1.6%	234,898 $1.91 Million
Q4 2018 Feb 05, 2019	SELL	$6.51 - $9.6 $70,308 - $103,680	-10,800 Reduced 4.46%	231,198 $1.87 Million
Q3 2018 Nov 07, 2018	SELL	$5.52 - $7.99 $34,224 - $49,538	-6,200 Reduced 2.5%	241,998 $1.85 Million
Q2 2018 Aug 10, 2018	SELL	$4.6 - $6.52 $216,052 - $306,231	-46,968 Reduced 15.91%	248,198 $1.42 Million
Q1 2018 May 08, 2018	BUY	$4.35 - $5.82 $76,555 - $102,426	17,599 Added 6.34%	295,166 $1.41 Million
Q4 2017 Feb 13, 2018	BUY	$4.16 - $5.33 $843,926 - $1.08 Million	202,867 Added 271.58%	277,567 $1.36 Million
Q3 2017 Nov 07, 2017	BUY	$4.1 - $5.97 $306,270 - $445,959	74,700	74,700 $392,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.